Natriuretic peptides as prognostic and diagnostic markers in Chagas' disease

Regulatory Peptides

Volumn 128, Issue 3, 2005, Pages 203-210

  Puyó, Ana M ^a   Scaglione, Jorge ^a   Auger, Sergio ^b   Cavallero, Susana ^a   Postan, Miriam ^c   Fernández, Belisario E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b Santojanni General Hospital   (Argentina)

^c Inst Nac de Parasitologia   (Argentina)

Author keywords

Atrial natriuretic factor; Chronic heart failure; Conduction defects; Myocarditis; Trypanosoma cruzi infection

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE;

CHAGAS DISEASE; CHRONIC DISEASE; DIAGNOSTIC ACCURACY; DISEASE MARKER; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CONDUCTION DISTURBANCE; HEART MUSCLE INJURY; HUMAN; INFLAMMATORY INFILTRATE; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; REVIEW; SURVIVAL TIME; TRYPANOSOMA CRUZI;

EID: 17444377937     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2005.01.001     Document Type: Article

References (52)

1. A.J. de Bold, H.B. Borenstein, A.T. Veress, and H. Sonnenberg A rapid and potent natriuretic response to intravenous injection of atrial myocardial extracts in rats Life Sci. 28 1981 89 94
2. M. Cantin, and J. Genest The heart and the atrial natriuretic factor Endocr. Rev. 6 1985 107 127
3. B.M. Brenner, B.J. Ballermann, M.E. Gunning, and M.L. Zeidel Diverse biological actions of atrial natriuretic peptide Physiol. Rev. 70 1990 665 699
4. C. Wei, D.M. Heublein, M.A. Perrella, A. Lerman, R.J. Rodeheffer, and C.G. Mac Gregor Natriuretic peptide system in human heart failure Circulation 88 1993 1004 1009
5. T. Sudoh, K. Kangawa, N. Minamino, and H. Matsuo A new natriuretic peptide in porcine brain Nature (London) 332 1988 78 81
6. N. Davidson, A. Naab, J. Hanson, N. Kennedy, W. Coutie, and A. Struthers Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction Am. J. Cardiol. 77 1996 828 831
7. T. Omland, A. Aakbaag, V. Bonarjee, K. Caidahl, R.T. Lie, and D.W. Nilsen Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide Circulation 93 1996 1963 1969
8. A.M. Richards, R. Doughty, M.G. Nicholls, S. Macmahon, H. Ikram, and N. Sharpe Neurohumoral prediction of benefit from carvedilol in ischemic left ventricular dysfunction Circulation 99 1999 786 792
9. J. Sadoshima, Y. Xu, H.Y.S. Slayter, and S. Izumo Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro Cell 75 1993 977 984
10. R. Schiebinger, and C.E. Gómez-Sánchez Endothelin: a potent stimulus of atrial natriuretic peptide secretion by superfused rat atria and its dependency on calcium Endocrinology 127 1990 119 125
11. E.R. Levin, D.G. Gardner, and W.K. Samson Natriuretic peptides N. Engl. J. Med. 339 1998 321 328
12. A.M. Puyó, G.M. Levin, I. Armando, A.S. Donoso, B.E. Fernández, and M.B. Barontini Increased plasma atrial natriuretic factor in catecholamine-producing tumors Clin. Exp. Hypertens. 21 1999 1129 1144
13. A.M. Puyó, G.W. Vega, A. Pellegrino de Iraldi, J. Corazza, M. Celentano, and M.I. Rosón Atrial natriuretic factor in two kidney-two clip renovascular hypertension Medicina (Bs. As.) 58 1998 165 170
14. H. Ruskoaho Cardiac hormones as diagnostic tools in heart failure Endocr. Rev. 24 3 2003 341 356
15. G. Takemura, H. Fujiwara, Y. Takatsu, and K. Nakao Ventricular expression of atrial natriuretic peptides in patients with myocarditis Int. J. Cardiol. 52 3 1995 213 217
16. A. Yoshida, T. Kand, T. Tanaka, T. Yokoyama, M. Kurimoto, and T. Tamura Interleukin-18 reduces expression of cardiac tumor necrosis factor-α and atrial natriuretic peptide in a murine model of viral myocarditis Life Sci. 70 11 2002 1225 1234
17. L.B. Stull, N.A. DiIulio, M. Yu, C.F. McTiernan, N.B. Ratliff, and V.K. Tuohy Alterations in cardiac function and gene expression during autoimmune myocarditis in mice J. Mol. Cell Cardiol. 32 2000 2035 2049
18. WHO Expert Committee Control of Chagas' disease WHO Tech. Rep. Ser. 811 1991 1 10
19. L. Sterin-Borda, G. Gorelik, M. Postan, S. González Cappa, and E. Borda Alterations in cardiac beta adrenergic receptor in chagasic mice and their association with the circulating beta adrenoceptor related antibodies Cardiovasc. Res. 41 1999 116 125
20. D. Iossa, V. Dequatro, D. De-Ping-Lee, B. Elcayan, T. Caeiro, and H. Palmero Pathogenesis of cardiac neuropathy in Chagas disease and the role of the autonomic nervous system J. Auton. Nerv. Syst. 30 1990 583 588
21. M.R. Bristow Why does the myocardium fail? Insights from basic science Lancet 352 1998 8 14
22. F. Kierszenbaum Views on the autoimmunity hypothesis for Chagas' disease pathogenesis FEMS Immunol. Med. Microbiol. 37 1 2003 1 11
23. M.V. Elizari La miocardiopatía chagásica. Perspectiva histórica Medicina (Bs. As.) 59 1999 25 40
24. L. Piazza, E.R. Rubiolo, E. Hliba, and N. Santamarina Atrial natriuretic factor in experimental Chagas' disease Mem. Inst. Oswaldo Cruz 87 1992 323 324
25. L.A. Piazza, A.J. de Bold, N. Santamarina, E. Hliba, and E.R. Rubiolo Atrial natriuretic factor in experimental Chagas' disease Parasitol. Res. 80 1994 78 80
26. M.V. Caliari, M. Lana, V.H.R. Leite, and W.L. Tafuri Morphological and morphometric study of atrial specific granules and other secretory components in dogs experimentally infected with Trypanosoma cruzi Int. J. Exp. Pathol. 76 1995 299 307
27. J. Scaglione, A.M. Puyó, H.A. Dupuy, M. Postan, and B.E. Fernández Behavior of atrial natriuretic factor in an experimental model of Trypanosoma cruzi infection in rats J. Parasitol. 87 2001 923 926
28. I.R. Sarda, M.L. de Bold, and A.J. de Bold Optimization of atrial natriuretic factor immunoassay Clin. Biochem. 22 1989 11 15
29. E. Moore, R. Gerner, and A. Franklin Culture of normal leucocytes J. Am. Med. Assoc. 199 1967 519 524
30. M. Postan, J.J. Bailey, J.A. Dvorak, J.P. McDaniel, and E.W. Pottala Studies of T. cruzi clones in inbred mice: III. Histopathological and electrocardiographical responses to chronic infection Am. J. Trop. Med. Hyg. 37 1987 541 549
31. M. Postan, J.P. McDaniel, and J.A. Dvorak Comparative studies of the infection of Lewis rats with four Trypanosoma cruzi clones Trans. R. Soc. Trop. Med. Hyg. 81 1987 415 419
32. L. Tonelli, J.L. Webster, K.L. Rapp, and E. Sternberg Neuroendocrine responses regulating susceptibility and resistance to autoimmune/inflammatory disease in inbred rat strains Immunol. Rev. 184 2001 203 211
33. B.M.Y. Cheung, and C.R. Kumana Natriuretic peptides-relevance in cardiac disease JAMA 280 1998 1983 1984
34. H.H. Chen, and J.C. Burnett Natriuretic peptides in the pathophysiology of congestive heart failure Curr. Cardiol. Rep. 2 2000 198 205
35. M. Yoshimura, H. Yasue, and Y. Ogawa Pathophysiological significance and clinical application of ANP and BNP in patients with heart failure Can. J. Physiol. Pharm. 79 2001 730 735
36. O. Gabrielli, A.M. Puyó, A. De Rosa, I. Armando, M.B. Barontini, and G.M. Levin Atenolol improves ventricular function and decreases plasma atrial natriuretic factor in chronic heart failure Auton. Autac. Pharm. 22 2002 261 268
37. A.M. Puyó, J. Scaglione, S. Auger, S. Cavallero, A.S. Donoso, and H.A. Dupuy Atrial natriuretic factor as marker of myocardial compromise in Chagas' disease Regul. Pept. 105 2002 139 143
38. J. Milei Patogenia R. Storino J. Melei Enfermedad de Chagas 1994 Mosby Doyma, Argentina 103 128
39. 1 adrenoceptor signalling in DOCA-salt hypertension in rats Cardiovasc. Res. 26 1992 878 885
40. S. Gottlieb, M. Kukin, D. Ahern, and M. Packer Prognostic importance of atrial natriuretic peptide in patients with chronic heart failure J. Am. Coll. Cardiol. 14 1989 812 817
41. L. Sterin-Borda, and E. Borda Overview of molecular mechanisms in chagasic cardiomyoneuropathy and achalasia Medicina (Bs. As.) 59 Suppl. II 1999 75 83
42. H. Huang, J. Chan, M. Wittner, L.A. Jelicks, S.A. Morris, and S.M. Factor Expression of cardiac cytokines and inducible form of nitric oxide synthase (NOS2) in Trypanosoma cruzi-infected mice J. Mol. Cell. Cardiol. 31 1999 75 88
43. K.M. Davis, L.C. Fish, D. Elahi, B.A. Clark, and K.L. Minaker Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly JAMA 267 1992 2625 2629
44. L.A. Benvenuti, V.D. Aiello, S.A.P. Palomino, and M.L. Higuchi Ventricular expression of atrial natriuretic peptide in chronic chagasic cardiomyopathy is not induced by myocarditis Int. J. Cardiol. 88 2003 57 61
45. T.L. Stevens, J.C. Burnett, M. Kinoshita, Y. Matsuda, and M.M. Redfield A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction J. Clin. Invest. 95 1995 1101 1108
46. The solvd investigators Comparative neurohormonal responses in patients with preserved and impaired left ventricular ejection fraction: results of the studies of left ventricular dysfunction (SOLVD) registry J. Am. Coll. Cardiol. 22 1993 146 153
47. M.J. Likoff, S.L. Chandler, and H.R. Kay Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy Am. J. Cardiol. 59 1987 634 638
48. P. Mathisen, C. Hall, and S. Simonsen Comparative study of atrial peptides ANF (1-98) and ANF (99-126) as diagnostic markers of atrial distension in patients with cardiac disease Scand. J. Clin. Lab. Invest. 53 1993 41 49
49. B.C. Stein, and R.I. Levin Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease Am. Heart J. 135 1998 914 923
50. T. Tsutamoto, A. Wada, K. Maeda, T. Hisanaga, Y. Maeda, and D. Fukai Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction Circulation 96 1997 509 516
51. J.A. De Lemos, and D.A. Morrow Brain natriuretic peptide measurement in acute coronary syndromes: ready for clinical application? Circulation 106 2002 2868 2870
52. A.L.P. Ribeiro, A.M. dos Reis, M.V.L. Barros, M.R. de Souza, A.L.L. Rocha, and A. Arantes Pérez Brain natriuretic peptide and left ventricular dysfunction in Chagas' disease Lancet 360 2002 461 462